Research Keyword: protease inhibitors

Purification and Biochemical Characterization of a Novel Fibrinolytic Enzyme from Culture Supernatant of Coprinus comatus

mycolabadmin

Scientists discovered and purified a powerful enzyme from the medicinal mushroom Coprinus comatus that can dissolve blood clots and prevent dangerous blood vessel blockages. This enzyme works in two ways: it can directly break down clots and also activate the body’s natural clot-dissolving systems. The enzyme is much smaller and safer than current blood-thinning medications, making it a promising natural alternative for treating heart disease and stroke.

Read More »

Indole-Based Compounds as Potential Drug Candidates for SARS-CoV-2

mycolabadmin

Scientists are searching for new treatments for COVID-19 by studying indole-containing compounds, which are found in many plants and can be made in laboratories. Some approved drugs with indole structures, like the antiviral drug Arbidol, have been repurposed to fight COVID-19. Researchers are also designing new indole compounds and using computer simulations to predict which ones might work best against the virus’s key proteins.

Read More »

Key Fungal Secreted Proteases in Coccidioidomycosis

mycolabadmin

Researchers studied how a dangerous fungus called Coccidioides causes disease by examining special proteins called proteases that the fungus secretes. They found that blocking these proteases prevented the fungus from forming the spherule structures that allow it to spread inside infected people. This discovery could lead to new treatments for coccidioidomycosis, a serious infection that affects people in the Southwest United States.

Read More »

HIV protease inhibitors restore amphotericin B activity against Candida

mycolabadmin

Researchers discovered that HIV protease inhibitors, medications commonly used to treat HIV, can significantly enhance the effectiveness of amphotericin B, a powerful antifungal drug. When combined, these medications work synergistically to kill the dangerous fungus Candida auris, reduce its ability to form protective biofilms, and lower infection levels. This finding suggests a promising new treatment strategy for multidrug-resistant fungal infections that currently pose a serious global health threat.

Read More »
Scroll to Top